News about Immunotherapy

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase surviv1

Clínic Barcelona

Institutional June 10 2020

A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom

Hospital Clínic de Barcelona-IDIBAPS and Cellnex have today signed an agreement to launch a multicentre research project that will allow better under1

Clínic Barcelona

Institutional May 26 2020

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Hospital Clínic – IDIBAPS (Barcelona) has founded Gyala Therapeutics, a new spin-off company focused on developing new CAR-T therapies for treating h1

Clínic Barcelona

Health Topics December 13 2019

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

In recent years, one of the strategies developed in the field of haematology is the modification of the patient’s immune system, also known as ‘immun1

2 2

page1
page2 , current page.

News about Immunotherapy

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

A consortium of European hospitals led by Clínic IDIBAPS is launching a cellular immunotherapy project to tackle COVID-19 with the support of Cellnex Telecom

A new cancer immune therapy spin-off of Hospital Clínic-IDIBAPS secures a 1.5 million-euro investment from Invivo Ventures

Immunotherapy: an innovative and efficient tool in the battle against haematological tumours

navigation between pages below

Subscribe to the Newsletter of Clínic